SlideShare a Scribd company logo
1 of 55
Download to read offline
What Every Clinician
  Needs to Know
 About Overdoses
        April 10-12, 2012
 Walt Disney World Swan Resort
Learning Objectives:
1. Describe the characteristics and risk factors
that may predispose patients to an overdose.
2. State the value of Poison Control Center
data in formulating strategies to reduce
prescription drug diversion health care
associated problems.
Disclosure Statement
•  Erin Johnson wishes to disclose the
   following:
•  Contract work with Miller Medical
   Communication, LLC.
•  No other relevant, real or apparent
   personal or professional financial
   relationships.
Common Characteristics Among
 Rx Opioid Overdose Decedents

      Erin Johnson, MPH,
   Utah Department of Health
In a nutshell
•  Those who die from overdose of
   prescription opioids:
  –    Suffer from pain
  –    Use more often than rx’d
  –    Lack social support
  –    Have been diagnosed with mental illness
  –    Smoke
  –    Have received treatment for substance abuse

•  Screen for/be aware of characteristics
  –  Closely monitor high risk patients or
     choose alternatives to opioids
•  Educate on using as directed
Utah News Clippings about Prescription Drug Death
Legislation in 2007
•  Research
  –  Causes, risk factors, solutions
•  Prescribing Guidelines
  –  “medical treatment and quality care
     guidelines that are scientifically based;
     and peer reviewed”
•  Educate
  –  Health care providers, Patients, Insurers,
     Public
To prevent and reduce the
misuse and abuse of
prescription pain medications in
Utah by providing information
and strategies regarding safe
use, safe storage, and safe
disposal of these potentially
dangerous drugs.
Bear Trap
Number of Unintentional Prescription
Opioid Drug Overdose Cases by Year: Utah,
               2000-2010




Utah Medical Examiner Data
What we knew
•  ME data:
  –  Sex
  –  BMI
  –  Age
  –  Drugs involved
What we wanted to know
•  Was there a common profile?
•  How much of the problem was:
  –  Misuse/abuse
  –  Using only as directed
•  Who should be the target of our
   educational efforts?
What we did
•  Next-of-kin interviews

•  Worked under Medical Examiner
  –  Determine manner of death


•  Interviews over telephone
Study Population

•  Died: October 26, 2008 – October 25,
   2009
•  Drug as primary cause of death
•  Accidental or undetermined manner of
   death
•  Utah residents
•  ≥12 years of age
Study Population Flowchart
              432
          drug deaths

            268 (62%)
     prescription opioid COD
Study Population Flowchart
              432
          drug deaths

            278 (64%)
     prescription opioid COD

            233 (87%)
    prescription opioid COD,
       no illicit drug COD
Study Population Flowchart
              432
          drug deaths

           278 (64%)
    prescription opioid COD

           254 (91%)
    prescription opioid COD
    with completed interview
Legitimate need
•  91.7% (222) took rx pain meds for pain
   during the year prior to death
•  80.3% (204) obtained pain meds from
   healthcare provider during last year of
   life
Demographics

•  53.2% male
•  79.1% between ages 25-54
•  66.9% overweight (BMI>25)
Social Support
•  65.9% were separated/divorced,
   widowed, or unmarried
•  70.7% attended church less than
   monthly
•  63.2% were unemployed during last 2
   months prior to death
•  23.2% lived alone at time of death
Potential Indicators of Misuse
•  52.9% took pain meds more often than
   prescribed
•  31.6% visited >1 doctor to get more rx
   pain medication
•  39.6% received rx pain meds from
   source other than healthcare provider
•  29.8% used rx pain meds for reasons
   other than to treat pain
Two Face
Complaints and Concerns
•  21.1% complained that provider was
   not prescribing enough pain
   medication
•  32.5% had a healthcare provider raise
   concerns about decedent’s use of
   pain medication
•  75.5% said others were concerned
   about decedent’s use of pain
   medication
Mental Health
•  54.3% diagnosed with mental illness (in
   lifetime)
  –  40.6% mood disorder
  –  15.4% anxiety disorder
•  24.4% hospitalized for mental illness
Substance Use
•  73.2% smoked daily at time of death
•  61.4% had used an illicit substance
   (ever)
•  53.1% received treatment for any
   substance abuse (ever)
Conclusions
•  Characteristics to keep in mind when
   starting/continuing opioids:
  –  Hx of substance abuse? Tx?
  –  Daily smoker?
  –  Mental illness?
  –  Social support system?
Conclusions….(cont.)
•  Things to discuss with patients:
  –  Dangers of using more often than
     prescribed
  –  Talk with family?
Study Objective and Design
    Identify risk factors for death
    People who died from prescription opioids
    People who used prescription opioids
    Compared populations
Data Sources: Decedents
    Medical examiner records
    Death certificates
    Next-of-kin interviews
Decedents (N = 254)
    October 26, 2008–October 25, 2009
    Prescription opioid cause of death
    Accidental or intent-undetermined manner of death
    Utah residents
    ≥18 years of age
    Interview completed by next-of-kin
Data Source: Comparison Group
    Behavioral Risk Factor Surveillance System (BRFSS)
    Self-reported
    Landline only
    Non-institutionalized
    Weighted to reflect state population
    Prescription pain medication questions added 2008
Comparison Group (N = 1,308)
    Utah 2008 BRFSS
    Used prescription opioid in prior 12 months
    Utah residents
    ≥18 years of age
Statistical Methods
    Exposure prevalence (prevalence of characteristics)
    Exposure prevalence ratios (EPR) as measure of
     association

                        Decedent prevalence
             EPR =
                       Comparison prevalence

    95% Confidence intervals (CI)
Pain Medication Source and Use
                       Prevalence (%)       EPR
Characteristic     Decedents Comparison   (95% CI)

       Obtained                              0.8
                     80.3       96.2
via prescription                          (0.8–0.9)

       Obtained                              4.3
                     35.8       8.3
via other source                          (3.2–5.4)

Used more than                               16.5
                     52.9       3.2
    prescribed                            (9.3–23.7)
Pain Type among Decedents


          No Acute
         pain pain
         9%   8%




         Chronic
          pain
          83%
Chronic Pain Comparison
              (Obtained via Prescription)
    Decedents (N = 191)           Comparison (N = 1253)
 Acute
pain only
                                            Acute
   6%
                                           pain only
                                             78%




            Chronic                        Chronic
             pain                           pain
             94%                            32%
                          EPR = 3.0
                      (95% CI = 2.7–3.3)
Body Mass Index (BMI)
 BMI category         Prevalence (%)        EPR
(Sex, BMI cat.)   Decedents Comparison    (95% CI)

        BMI <25     33.1       33.6      1.0 (0.9–1.1)
BMI ≥25 but <30     28.1       35.6      0.8 (0.7–0.9)
        BMI ≥30     38.8       30.8      1.3 (1.1–1.4)
Males, BMI ≥30      34.4       34.6      1.0 (0.8–1.2)
 Females, BMI
           ≥30      44.1       28.0      1.6 (1.3–1.8)
        BMI <25     33.1       33.6      1.0 (0.9–1.1)
Risk by Specific Opioid
                     Prevalence (%)       EPR
Characteristic   Decedents Comparison   (95% CI)
                                           15.5
    Methadone      28.1        1.8      (6.3–24.6)
                                           5.7
      Morphine     13.4        2.4      (3.5–7.9)
                                           1.3
    Oxycodone      37.9       28.4      (1.2–1.5)
                                           0.4
  Hydrocodone      25.3       69.6      (0.3–0.4)
Unemployed and Lived Alone
                     Prevalence (%)        EPR
Characteristic   Decedents Comparison    (95% CI)

  Unemployed       63.2       39.0      1.6 (1.5–1.8)
   Lived alone     23.2       6.7       3.5 (2.9–4.0)
Numbers of Drugs
      as Decedent CODs (N = 254)
                  Number of   Percentage of
Number of Drugs   Decedents   Decedents (%)

      1              56           22.0

      2              56           22.0

      3              76           29.9

      4              44           17.3
      ≥5             22            8.7
Illicit Substance Use History (Lifetime)
        among Decedents (N = 251)
                    Number of   Percentage of
Type of Drugs       Decedents   Decedents (%)

    Heroin             52           20.7


    Cocaine            77           30.7

  Any illicit
                       154          61.4
  substance
Illicit substance
                       129          51.4
  use treatment
Alcohol Use and Cause of Death
    88% of decedents ever drank
    14% of decedents drank daily in last 2 months
    2% of comparison group drank daily in last month
    COD among decedents: 10%
Mental Illness
                     Prevalence (%)       EPR
Characteristic   Decedents Comparison   (95% CI)
                                           2.2
Depressed/FMD      30.3        13.5
                                        (1.8–2.6)
Education and Smoking
                        Prevalence (%)       EPR
Characteristic      Decedents Comparison   (95% CI)

 Did not graduate                             3.0
                      18.5       6.2
from high school                           (2.0–3.9)
                                              5.6
   Smoked daily       54.5       9.7
                                           (4.4–6.9)
   Smoked daily
                                              5.0
    (education-       49.1       9.7
                                           (4.0–6.1)
      adjusted)
Marital Status and Health Insurance
                     Prevalence (%)       EPR
Characteristic   Decedents Comparison   (95% CI)

     Divorced/                             3.7
                   34.6       9.4
     Separated                          (3.0–4.4)

                                           2.3
     Uninsured     29.2       12.5
                                        (1.8–2.8)
Prescription Opioid Use and Chronic Pain
    Use outside prescription increases risk
    Not all decedents used outside prescription
    Majority of decedents obtained by prescription
    Chronic pain in majority of decedents
       Prevalence higher if obtained via prescription
Education and Smoking
    Low education level
       Predispose to lack of insurance and other factors

    Smoking rates higher among low educated
       Association mildly confounded by education

    Smoking rates higher among substance abusers
       Could confound association
       Population susceptible to addiction
Marital Status and Health Insurance
    Divorced/separated
       Indicates lack of social support
       Increase risky drug use
       Decrease chance of timely care

    Lack of health insurance
       Limits access to care
       Consequence of chronic pain or substance abuse
Limitations
    Interview response influences
       Social desirability
       Recall
       Lack of knowledge about decedents

    Incomplete comparability of data sources
    Potential risk factors not analyzed
       Illicit substance use
       Mental illness

    Confounding variables
Conclusion
    Risk of death complicated
    Use outside prescription bounds risky
    Decedents needed chronic pain therapy
    Other factors important
    Providers can recognize risk and control exposure
Recommendations
    Prescribers should screen chronic pain patients
    Update screening tools to include risk factors
    Continue research on risk factors
       Smoking
       Illicit substance use
       Mental illness
Acknowledgments
    Comparison data prepared by William Lanier, EIS
    Utah Department of Health:
         Todd Grey
         Robert Rolfs
         Jonathan Anderson
         Kris Russell
         Michael Friedrichs

More Related Content

What's hot

Rx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_groupRx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_groupOPUNITE
 
Medication Abuse Handouts by Rand L. Kannenberg
Medication Abuse Handouts by Rand L. KannenbergMedication Abuse Handouts by Rand L. Kannenberg
Medication Abuse Handouts by Rand L. KannenbergRand Kannenberg
 
Polypharmacy full guidance v2
Polypharmacy full guidance v2Polypharmacy full guidance v2
Polypharmacy full guidance v2maykamen
 
Pharmacovigilance & Adverse drug reaction
Pharmacovigilance & Adverse drug reactionPharmacovigilance & Adverse drug reaction
Pharmacovigilance & Adverse drug reactionRahul Bhati
 
Pharmacovigilance-an overview
Pharmacovigilance-an overviewPharmacovigilance-an overview
Pharmacovigilance-an overviewDr. Pramod Kumar
 
Polypharmacy in elderly patients:an intervention study in therapeutic management
Polypharmacy in elderly patients:an intervention study in therapeutic managementPolypharmacy in elderly patients:an intervention study in therapeutic management
Polypharmacy in elderly patients:an intervention study in therapeutic managementRosario Falanga
 
Adverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reportingAdverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reportingTHUSHARA MOHAN
 
Methadone - A Potted Guide
Methadone - A Potted GuideMethadone - A Potted Guide
Methadone - A Potted Guidemolyneux1000
 
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosalesRx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosalesOPUNITE
 
ADR Pharmacist Reporting
ADR Pharmacist ReportingADR Pharmacist Reporting
ADR Pharmacist ReportingRishi Kumar
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactionsYousra Ashraf
 
Rx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_waltonRx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_waltonOPUNITE
 
Introduction to Adverse Drug Reactions
Introduction to Adverse Drug ReactionsIntroduction to Adverse Drug Reactions
Introduction to Adverse Drug ReactionsAbhik Seal
 

What's hot (20)

Rx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_groupRx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_group
 
Medication Abuse Handouts by Rand L. Kannenberg
Medication Abuse Handouts by Rand L. KannenbergMedication Abuse Handouts by Rand L. Kannenberg
Medication Abuse Handouts by Rand L. Kannenberg
 
Prescription and Over-the Counter Drug Misuse and Abuse
Prescription and Over-the Counter Drug Misuse and AbusePrescription and Over-the Counter Drug Misuse and Abuse
Prescription and Over-the Counter Drug Misuse and Abuse
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Polypharmacy full guidance v2
Polypharmacy full guidance v2Polypharmacy full guidance v2
Polypharmacy full guidance v2
 
Pharmacovigilance & Adverse drug reaction
Pharmacovigilance & Adverse drug reactionPharmacovigilance & Adverse drug reaction
Pharmacovigilance & Adverse drug reaction
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Pharmacovigilance-an overview
Pharmacovigilance-an overviewPharmacovigilance-an overview
Pharmacovigilance-an overview
 
Adr
AdrAdr
Adr
 
Polypharmacy in elderly patients:an intervention study in therapeutic management
Polypharmacy in elderly patients:an intervention study in therapeutic managementPolypharmacy in elderly patients:an intervention study in therapeutic management
Polypharmacy in elderly patients:an intervention study in therapeutic management
 
Adverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reportingAdverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reporting
 
Methadone - A Potted Guide
Methadone - A Potted GuideMethadone - A Potted Guide
Methadone - A Potted Guide
 
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosalesRx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
 
Polypharmacy
PolypharmacyPolypharmacy
Polypharmacy
 
ADR Pharmacist Reporting
ADR Pharmacist ReportingADR Pharmacist Reporting
ADR Pharmacist Reporting
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Pharmacotherapy and adherence to beers criteria (providers)
Pharmacotherapy and adherence to beers criteria (providers)Pharmacotherapy and adherence to beers criteria (providers)
Pharmacotherapy and adherence to beers criteria (providers)
 
Rx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_waltonRx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_walton
 
Pharmacovigilance orientation
Pharmacovigilance orientationPharmacovigilance orientation
Pharmacovigilance orientation
 
Introduction to Adverse Drug Reactions
Introduction to Adverse Drug ReactionsIntroduction to Adverse Drug Reactions
Introduction to Adverse Drug Reactions
 

Viewers also liked (7)

The Partnership
The PartnershipThe Partnership
The Partnership
 
Statement of the problem paper-1
Statement of the problem paper-1Statement of the problem paper-1
Statement of the problem paper-1
 
Drugs of Abuse: Opiates
Drugs of Abuse: OpiatesDrugs of Abuse: Opiates
Drugs of Abuse: Opiates
 
Medical Errors within the U.S. Healthcare System
Medical Errors within the U.S. Healthcare SystemMedical Errors within the U.S. Healthcare System
Medical Errors within the U.S. Healthcare System
 
Hw499 week 1 lecture notes
Hw499 week 1 lecture notesHw499 week 1 lecture notes
Hw499 week 1 lecture notes
 
Medical errors
Medical errorsMedical errors
Medical errors
 
Icecreammark
IcecreammarkIcecreammark
Icecreammark
 

Similar to Erin Johnson

Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...
Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...
Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...HMO Research Network
 
Disparities in Antihypertensive Medication Adherence ADAMS
Disparities in Antihypertensive Medication Adherence ADAMSDisparities in Antihypertensive Medication Adherence ADAMS
Disparities in Antihypertensive Medication Adherence ADAMSHMO Research Network
 
Opioid Usage Trends in Rheumatoid Arthritis_20151005_SJA
Opioid Usage Trends in Rheumatoid Arthritis_20151005_SJAOpioid Usage Trends in Rheumatoid Arthritis_20151005_SJA
Opioid Usage Trends in Rheumatoid Arthritis_20151005_SJAJ.A. Zamora-Legoff
 
Lynn Webster
Lynn  WebsterLynn  Webster
Lynn WebsterOPUNITE
 
Pregnant women with anxiety and other mood disorders more likely to report us...
Pregnant women with anxiety and other mood disorders more likely to report us...Pregnant women with anxiety and other mood disorders more likely to report us...
Pregnant women with anxiety and other mood disorders more likely to report us...Δρ. Γιώργος K. Κασάπης
 
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simba Takuva
 
The windup1
The windup1The windup1
The windup1wcrdm8
 
401 vehu pccpain_burgo_hunt-8.5
401 vehu pccpain_burgo_hunt-8.5401 vehu pccpain_burgo_hunt-8.5
401 vehu pccpain_burgo_hunt-8.5Lucile Burgo
 
7. hcv treatment for pwid final
7. hcv treatment for pwid final7. hcv treatment for pwid final
7. hcv treatment for pwid finalantoine piaton
 
Stoppen Met Antidepressiva
Stoppen Met AntidepressivaStoppen Met Antidepressiva
Stoppen Met AntidepressivaRobHeerdink
 
The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...HTAi Bilbao 2012
 
Utah’s All Payer Claims Dataset: A vital resource for health reform
Utah’s All Payer Claims Dataset: A  vital resource for health reformUtah’s All Payer Claims Dataset: A  vital resource for health reform
Utah’s All Payer Claims Dataset: A vital resource for health reformState of Utah, Salt Lake City
 
캐나다 마더리스크프로그램연수기 - 최준식 교수
캐나다 마더리스크프로그램연수기 - 최준식 교수캐나다 마더리스크프로그램연수기 - 최준식 교수
캐나다 마더리스크프로그램연수기 - 최준식 교수mothersafe
 
22 patricia millernov1
22 patricia millernov122 patricia millernov1
22 patricia millernov1CBRC
 
Suicidality Poster References.docx
Suicidality Poster References.docxSuicidality Poster References.docx
Suicidality Poster References.docxPaul Coelho, MD
 
11H00_3_Michael Farrell.pptx
11H00_3_Michael Farrell.pptx11H00_3_Michael Farrell.pptx
11H00_3_Michael Farrell.pptxEl Viajero
 
Tobacco use and hiv
Tobacco use and hivTobacco use and hiv
Tobacco use and hivanangsowah
 
Patologie infettive e doppia diagnosi
Patologie infettive e doppia diagnosiPatologie infettive e doppia diagnosi
Patologie infettive e doppia diagnosiFabrizio Starace
 

Similar to Erin Johnson (20)

Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...
Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...
Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...
 
Disparities in Antihypertensive Medication Adherence ADAMS
Disparities in Antihypertensive Medication Adherence ADAMSDisparities in Antihypertensive Medication Adherence ADAMS
Disparities in Antihypertensive Medication Adherence ADAMS
 
Opioid Usage Trends in Rheumatoid Arthritis_20151005_SJA
Opioid Usage Trends in Rheumatoid Arthritis_20151005_SJAOpioid Usage Trends in Rheumatoid Arthritis_20151005_SJA
Opioid Usage Trends in Rheumatoid Arthritis_20151005_SJA
 
Lynn Webster
Lynn  WebsterLynn  Webster
Lynn Webster
 
Pregnant women with anxiety and other mood disorders more likely to report us...
Pregnant women with anxiety and other mood disorders more likely to report us...Pregnant women with anxiety and other mood disorders more likely to report us...
Pregnant women with anxiety and other mood disorders more likely to report us...
 
Smoking cessation and mental ill health
Smoking cessation and mental ill healthSmoking cessation and mental ill health
Smoking cessation and mental ill health
 
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
 
The windup1
The windup1The windup1
The windup1
 
401 vehu pccpain_burgo_hunt-8.5
401 vehu pccpain_burgo_hunt-8.5401 vehu pccpain_burgo_hunt-8.5
401 vehu pccpain_burgo_hunt-8.5
 
7. hcv treatment for pwid final
7. hcv treatment for pwid final7. hcv treatment for pwid final
7. hcv treatment for pwid final
 
Stoppen Met Antidepressiva
Stoppen Met AntidepressivaStoppen Met Antidepressiva
Stoppen Met Antidepressiva
 
The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...
 
Utah’s All Payer Claims Dataset: A vital resource for health reform
Utah’s All Payer Claims Dataset: A  vital resource for health reformUtah’s All Payer Claims Dataset: A  vital resource for health reform
Utah’s All Payer Claims Dataset: A vital resource for health reform
 
Twillman preventing rx abuse
Twillman preventing rx abuseTwillman preventing rx abuse
Twillman preventing rx abuse
 
캐나다 마더리스크프로그램연수기 - 최준식 교수
캐나다 마더리스크프로그램연수기 - 최준식 교수캐나다 마더리스크프로그램연수기 - 최준식 교수
캐나다 마더리스크프로그램연수기 - 최준식 교수
 
22 patricia millernov1
22 patricia millernov122 patricia millernov1
22 patricia millernov1
 
Suicidality Poster References.docx
Suicidality Poster References.docxSuicidality Poster References.docx
Suicidality Poster References.docx
 
11H00_3_Michael Farrell.pptx
11H00_3_Michael Farrell.pptx11H00_3_Michael Farrell.pptx
11H00_3_Michael Farrell.pptx
 
Tobacco use and hiv
Tobacco use and hivTobacco use and hiv
Tobacco use and hiv
 
Patologie infettive e doppia diagnosi
Patologie infettive e doppia diagnosiPatologie infettive e doppia diagnosi
Patologie infettive e doppia diagnosi
 

More from OPUNITE

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynoteOPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_finalOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyOPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliOPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattOPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 

More from OPUNITE (20)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 

Recently uploaded

Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Deliverynehamumbai
 
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...hotbabesbook
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableNehru place Escorts
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Servicevidya singh
 
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escortsaditipandeya
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...narwatsonia7
 
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...narwatsonia7
 
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...indiancallgirl4rent
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...chandars293
 
Chandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD availableChandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD availableDipal Arora
 
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...Taniya Sharma
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...narwatsonia7
 
Call Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...aartirawatdelhi
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...Garima Khatri
 

Recently uploaded (20)

Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
 
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
 
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
 
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
 
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
 
Chandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD availableChandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD available
 
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
 
Call Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
 

Erin Johnson

  • 1. What Every Clinician Needs to Know About Overdoses April 10-12, 2012 Walt Disney World Swan Resort
  • 2. Learning Objectives: 1. Describe the characteristics and risk factors that may predispose patients to an overdose. 2. State the value of Poison Control Center data in formulating strategies to reduce prescription drug diversion health care associated problems.
  • 3. Disclosure Statement •  Erin Johnson wishes to disclose the following: •  Contract work with Miller Medical Communication, LLC. •  No other relevant, real or apparent personal or professional financial relationships.
  • 4. Common Characteristics Among Rx Opioid Overdose Decedents Erin Johnson, MPH, Utah Department of Health
  • 5. In a nutshell •  Those who die from overdose of prescription opioids: –  Suffer from pain –  Use more often than rx’d –  Lack social support –  Have been diagnosed with mental illness –  Smoke –  Have received treatment for substance abuse •  Screen for/be aware of characteristics –  Closely monitor high risk patients or choose alternatives to opioids •  Educate on using as directed
  • 6. Utah News Clippings about Prescription Drug Death
  • 7. Legislation in 2007 •  Research –  Causes, risk factors, solutions •  Prescribing Guidelines –  “medical treatment and quality care guidelines that are scientifically based; and peer reviewed” •  Educate –  Health care providers, Patients, Insurers, Public
  • 8. To prevent and reduce the misuse and abuse of prescription pain medications in Utah by providing information and strategies regarding safe use, safe storage, and safe disposal of these potentially dangerous drugs.
  • 10. Number of Unintentional Prescription Opioid Drug Overdose Cases by Year: Utah, 2000-2010 Utah Medical Examiner Data
  • 11. What we knew •  ME data: –  Sex –  BMI –  Age –  Drugs involved
  • 12. What we wanted to know •  Was there a common profile? •  How much of the problem was: –  Misuse/abuse –  Using only as directed •  Who should be the target of our educational efforts?
  • 13. What we did •  Next-of-kin interviews •  Worked under Medical Examiner –  Determine manner of death •  Interviews over telephone
  • 14. Study Population •  Died: October 26, 2008 – October 25, 2009 •  Drug as primary cause of death •  Accidental or undetermined manner of death •  Utah residents •  ≥12 years of age
  • 15. Study Population Flowchart 432 drug deaths 268 (62%) prescription opioid COD
  • 16. Study Population Flowchart 432 drug deaths 278 (64%) prescription opioid COD 233 (87%) prescription opioid COD, no illicit drug COD
  • 17. Study Population Flowchart 432 drug deaths 278 (64%) prescription opioid COD 254 (91%) prescription opioid COD with completed interview
  • 18. Legitimate need •  91.7% (222) took rx pain meds for pain during the year prior to death •  80.3% (204) obtained pain meds from healthcare provider during last year of life
  • 19. Demographics •  53.2% male •  79.1% between ages 25-54 •  66.9% overweight (BMI>25)
  • 20. Social Support •  65.9% were separated/divorced, widowed, or unmarried •  70.7% attended church less than monthly •  63.2% were unemployed during last 2 months prior to death •  23.2% lived alone at time of death
  • 21. Potential Indicators of Misuse •  52.9% took pain meds more often than prescribed •  31.6% visited >1 doctor to get more rx pain medication •  39.6% received rx pain meds from source other than healthcare provider •  29.8% used rx pain meds for reasons other than to treat pain
  • 23.
  • 24. Complaints and Concerns •  21.1% complained that provider was not prescribing enough pain medication •  32.5% had a healthcare provider raise concerns about decedent’s use of pain medication •  75.5% said others were concerned about decedent’s use of pain medication
  • 25. Mental Health •  54.3% diagnosed with mental illness (in lifetime) –  40.6% mood disorder –  15.4% anxiety disorder •  24.4% hospitalized for mental illness
  • 26. Substance Use •  73.2% smoked daily at time of death •  61.4% had used an illicit substance (ever) •  53.1% received treatment for any substance abuse (ever)
  • 27. Conclusions •  Characteristics to keep in mind when starting/continuing opioids: –  Hx of substance abuse? Tx? –  Daily smoker? –  Mental illness? –  Social support system?
  • 28. Conclusions….(cont.) •  Things to discuss with patients: –  Dangers of using more often than prescribed –  Talk with family?
  • 29. Study Objective and Design   Identify risk factors for death   People who died from prescription opioids   People who used prescription opioids   Compared populations
  • 30. Data Sources: Decedents   Medical examiner records   Death certificates   Next-of-kin interviews
  • 31. Decedents (N = 254)   October 26, 2008–October 25, 2009   Prescription opioid cause of death   Accidental or intent-undetermined manner of death   Utah residents   ≥18 years of age   Interview completed by next-of-kin
  • 32. Data Source: Comparison Group   Behavioral Risk Factor Surveillance System (BRFSS)   Self-reported   Landline only   Non-institutionalized   Weighted to reflect state population   Prescription pain medication questions added 2008
  • 33. Comparison Group (N = 1,308)   Utah 2008 BRFSS   Used prescription opioid in prior 12 months   Utah residents   ≥18 years of age
  • 34. Statistical Methods   Exposure prevalence (prevalence of characteristics)   Exposure prevalence ratios (EPR) as measure of association Decedent prevalence EPR = Comparison prevalence   95% Confidence intervals (CI)
  • 35. Pain Medication Source and Use Prevalence (%) EPR Characteristic Decedents Comparison (95% CI) Obtained 0.8 80.3 96.2 via prescription (0.8–0.9) Obtained 4.3 35.8 8.3 via other source (3.2–5.4) Used more than 16.5 52.9 3.2 prescribed (9.3–23.7)
  • 36. Pain Type among Decedents No Acute pain pain 9% 8% Chronic pain 83%
  • 37. Chronic Pain Comparison (Obtained via Prescription) Decedents (N = 191) Comparison (N = 1253) Acute pain only Acute 6% pain only 78% Chronic Chronic pain pain 94% 32% EPR = 3.0 (95% CI = 2.7–3.3)
  • 38. Body Mass Index (BMI) BMI category Prevalence (%) EPR (Sex, BMI cat.) Decedents Comparison (95% CI) BMI <25 33.1 33.6 1.0 (0.9–1.1) BMI ≥25 but <30 28.1 35.6 0.8 (0.7–0.9) BMI ≥30 38.8 30.8 1.3 (1.1–1.4) Males, BMI ≥30 34.4 34.6 1.0 (0.8–1.2) Females, BMI ≥30 44.1 28.0 1.6 (1.3–1.8) BMI <25 33.1 33.6 1.0 (0.9–1.1)
  • 39. Risk by Specific Opioid Prevalence (%) EPR Characteristic Decedents Comparison (95% CI) 15.5 Methadone 28.1 1.8 (6.3–24.6) 5.7 Morphine 13.4 2.4 (3.5–7.9) 1.3 Oxycodone 37.9 28.4 (1.2–1.5) 0.4 Hydrocodone 25.3 69.6 (0.3–0.4)
  • 40. Unemployed and Lived Alone Prevalence (%) EPR Characteristic Decedents Comparison (95% CI) Unemployed 63.2 39.0 1.6 (1.5–1.8) Lived alone 23.2 6.7 3.5 (2.9–4.0)
  • 41. Numbers of Drugs as Decedent CODs (N = 254) Number of Percentage of Number of Drugs Decedents Decedents (%) 1 56 22.0 2 56 22.0 3 76 29.9 4 44 17.3 ≥5 22 8.7
  • 42. Illicit Substance Use History (Lifetime) among Decedents (N = 251) Number of Percentage of Type of Drugs Decedents Decedents (%) Heroin 52 20.7 Cocaine 77 30.7 Any illicit 154 61.4 substance Illicit substance 129 51.4 use treatment
  • 43.
  • 44. Alcohol Use and Cause of Death   88% of decedents ever drank   14% of decedents drank daily in last 2 months   2% of comparison group drank daily in last month   COD among decedents: 10%
  • 45. Mental Illness Prevalence (%) EPR Characteristic Decedents Comparison (95% CI) 2.2 Depressed/FMD 30.3 13.5 (1.8–2.6)
  • 46. Education and Smoking Prevalence (%) EPR Characteristic Decedents Comparison (95% CI) Did not graduate 3.0 18.5 6.2 from high school (2.0–3.9) 5.6 Smoked daily 54.5 9.7 (4.4–6.9) Smoked daily 5.0 (education- 49.1 9.7 (4.0–6.1) adjusted)
  • 47. Marital Status and Health Insurance Prevalence (%) EPR Characteristic Decedents Comparison (95% CI) Divorced/ 3.7 34.6 9.4 Separated (3.0–4.4) 2.3 Uninsured 29.2 12.5 (1.8–2.8)
  • 48. Prescription Opioid Use and Chronic Pain   Use outside prescription increases risk   Not all decedents used outside prescription   Majority of decedents obtained by prescription   Chronic pain in majority of decedents   Prevalence higher if obtained via prescription
  • 49. Education and Smoking   Low education level   Predispose to lack of insurance and other factors   Smoking rates higher among low educated   Association mildly confounded by education   Smoking rates higher among substance abusers   Could confound association   Population susceptible to addiction
  • 50. Marital Status and Health Insurance   Divorced/separated   Indicates lack of social support   Increase risky drug use   Decrease chance of timely care   Lack of health insurance   Limits access to care   Consequence of chronic pain or substance abuse
  • 51. Limitations   Interview response influences   Social desirability   Recall   Lack of knowledge about decedents   Incomplete comparability of data sources   Potential risk factors not analyzed   Illicit substance use   Mental illness   Confounding variables
  • 52. Conclusion   Risk of death complicated   Use outside prescription bounds risky   Decedents needed chronic pain therapy   Other factors important   Providers can recognize risk and control exposure
  • 53. Recommendations   Prescribers should screen chronic pain patients   Update screening tools to include risk factors   Continue research on risk factors   Smoking   Illicit substance use   Mental illness
  • 54.
  • 55. Acknowledgments   Comparison data prepared by William Lanier, EIS   Utah Department of Health:   Todd Grey   Robert Rolfs   Jonathan Anderson   Kris Russell   Michael Friedrichs